FLORENCE FAUVELLE

- Mallet D., Dufourd T., Decourt M, Carcenac C., Bossù P., Verlin L., Fernagut P.O., Benoit-Marand M., Spalletta G., Barbier E.L., Carnicella S., Sgambato V., Fauvelle F.*, Boulet S.* (co-senior authors). A metabolic biomarker predict Parkinson’s disease at early stages in patients and in animal models, Journal of Clinical Investigations DOI: 10.1172/JCI146400, 2022.

- Mallet D., Goutaudier R., Dufourd T., Barbier EL., Carnicella S., Colca JR., Fauvelle F.* Boulet S.* (* Co-senior authors). Re-routing metabolism by the mitochondrial pyruvate carrier inhibitor MSDC-0160 attenuates neurodegeneration in a rat model of Parkinson’s disease, Molecular Neurobiology, DOI: 10.1007/s12035-022-02962-9, 2022.

- Hamelin S., Stupar V., Maziere L., Guo J., Labriji W., Liu C., Bretagnolle L., Parrot S., Barbier EL., Depaulis A.*, Fauvelle F* (co-senior authors). In vivo GABA increase as a biomarker of the epileptogenic zone: an unbiased metabolomics approach, Epilepsia doi.org/10.1111/epi.16768, 2020